Learn more

CATARINENSE S A LAB

Overview
  • Total Patents
    24
About

CATARINENSE S A LAB has a total of 24 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Brazil, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and machines are SCHULZ HANS-HERRMANN, KORTH RUTH and EFAMOL LTD.

Patent filings per year

Chart showing CATARINENSE S A LABs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Velasco Irineu Tadeu 12
#2 Fujii Tadafissa 11
#3 Raes Luc Edmond Leon Andre 8
#4 Silva Filho Ney Osvaldo 8
#5 Pontieri Vera 7
#6 Fernandes Celia Ivete 7
#7 Scalabrini Neto Augusto 6
#8 Neto Augusto Scalabrini 6
#9 Moreira Eduardo Augusto 5
#10 De Carvalho Carlos Eduardo 5

Latest patents

Publication Filing date Title
WO2011060513A1 PHARMACEUTICAL COMPOSITION COMPRISING CINCHONAINS Ia AND Ib, PROCESS FOR PREPARING AN EPIMERIC MIXTURE OF CINCHONAINS Ia AND Ib, USE AND METHOD FOR REVERTING/COMBATING VENTRICULAR FIBRILLATION
BRPI0505597A product use comprising vaginal material of the species trichilia sp. for combating inflammatory states and pharmaceutical composition comprising plant material for combating inflammatory states
BRPI0408632A use of product comprising plant material of the species trichilia sp. associated or not with other plant extracts for reversal / combat and / or prevention of ventricular fibrillation; pharmaceutical composition comprising said plant material for reversing / combating and / or preventing ventricular fibrillation; method for reversal / combat and / or prevention of ventricular fibrillation
BR0302750A Product use comprising plant material of the species trichilia sp. associated or not for the reversal / combat of ventricular fibrillation; pharmaceutical composition comprising said plant material for reversing / combating ventricular fibrillation; method for reversing / combating ventricular fibrillation using said plant material; use of said plant material for the production of a pharmaceutical composition for reversing / combating ventricular fibrillation
BR0102184A Use of product comprising catuama extract as an antidepressant agent and in anxiety disorders, pharmaceutical composition comprising such product for treating or preventing depression and / or anxiety disorders, method for treating or preventing depression and / or anxiety disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing depression and / or anxiety disorders
BR0102185A Use of product comprising catuama extract as an antioxidant or cerebral vasodilating agent, pharmaceutical composition comprising such product for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals, method for the prophylaxis or treatment of cerebral vascular disorders and disorders caused by improper pressing of free radicals using said product and use of said product for the production of a pharmaceutical composition, for the prophylaxis or treatment of vascular disorders and disorders caused by the improper presence of free radicals
BR0102186A Use of product comprising catuama extract as antithromboembolic agent, pharmaceutical composition comprising such product for treatment or prevention of thromboembolic disorders, method for treating thromboembolic disorders using said product and use of said product for producing a pharmaceutical composition for treating or preventing thromboembolic disorders
BR9703946A Use of selected plant material of the trichilia species for the preparation of pharmaceutical formulations and pharmaceutical compositions containing said plant material